drugset / Trial / NCT04773301

Comparative Study Between Levobupivacaine and Ropivacaine in the Hip Fractures of the Elderly

NCT04773301

RandomizedParallel-groupOpen-labelTreatment

Summary

Prospective, low-level, non-commercial intervention, comparative clinical trial (phase IV) of balanced, randomized groups, to compare the analgesic efficacy of the local anesthetics Ropivacaine and Levobupivacaine in peripheral nerve block in hip fracture surgery in the elderly .

Timeline

Start
2021-02-13
Primary completion
2021-11-26
Completion
2021-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Levobupivacaine Other / unclassified 0.25 %
Subject Levobupivacaine Other / unclassified 7.5 mg/ml
Subject Levobupivacaine Other / unclassified 20 ml
Subject Ropivacaine Other / unclassified 0.375 %
Subject Ropivacaine Other / unclassified 2 mg/ml
Subject Ropivacaine Other / unclassified 20 ml

Indications